Abridged CVs
PROF. DR. DR. C. C. GEILEN
PROF. DR. DR. C. C. GEILEN
Publications »
Born 28 June 1960 in Berlin, married with three children
Education
Other Academic Activities
PATENTS
Born 28 June 1960 in Berlin, married with three children
Education
- 1979 - 1986 | Studied human medicine, Free University of Berlin
- 1982 - 1988 | Studied chemistry / biochemistry, Free University of Berlin
Licensed to practise as a physician - 1988 | PhD in human medicine, Free University of Berlin
- 1993 | PhD in chemistry, Free University of Berlin
- 1986 - 1988 | Doctoral candidate, Institute for Molecular Biology and Biochemistry, FU Berlin (Prof. Dr. R.T.C. Huang/Prof. Dr. W. Reutter)
- 1988 - 1993 | Research fellow, Institute for Molecular Biology and Biochemistry, FU Berlin (Prof. Dr. W. Reutter), Visiting research fellow, University of Milan (Prof. Dr. G. Tettamanti)
- 1992 | DFG scholar and visiting research fellow, Purdue University, West Lafayette/USA, (Prof. Dr. D. J. Morré)
- 1993 - 1996 | Research associate, Hospital and Outpatients Centre for Dermatology, Benjamin Franklin University Hospital Campus at the FU Berlin (Director: Prof. Dr. Prof. Dr. h.c. C. E. Orfanos)
- 1995 | Habilitation in Physiological Chemistry, Department of Basic Medical Sciences, FU Berlin
- 1996 | Research assistant, Hospital and Outpatients Centre for Dermatology, Benjamin Franklin University Hospital Campus at the FU Berlin
- 1997 | Consultant for dermatology and venerology, Appointment as head of department, Hospital and Outpatients Centre for Dermatology, Benjamin Franklin University Hospital at the FU Berlin
- 1999 | Further qualification in allergology
- 1999 | Habilitation in dermatology and venerology, Department of Human Medicine, FU Berlin
- 2000 | Senior consultant and assistant medical director, Hospital and Outpatients Centre for Dermatology, Benjamin Franklin University Hospital Campus at the FU Berlin
- 2000 | Extraordinary Professor, Department of Human Medicine, FU Berlin, Enters the private group practice “Dermatologie am Kurfürstendamm”, Founds CCG Consulting Berlin GmbH, CEO
- 1988 | Doctorate in Human Medicine, FU Berlin, Doctoral thesis on: “Investigations of the Phosphatidylcholine Metabolism in MDCK Cells”,
Doctorate in Chemistry, FU Berlin, Doctoral thesis on: “2-Desoxy-D-galactose and 2-Desoxy-2-fluoro-D-galactose: Synthesis and Effects of possible new Modulators of the Glycoconjugate Metabolism.”
- 1995 | Habilitation, Venia legendi for Physiological Chemistry, Department of Basic Medical Sciences, FU Berlin. Habilitation thesis on: “Regulation of the Phosphatidylcholine Metabolism through CTP: Phosphocholine Cytidylyl Transferase in normal and malignant degenerated Cells.”
- 1999 | Habilitation, Venia legendi for Dermatology and Venerology, Department of Human Medicine, FU Berlin. Habilitation thesis on: “Psoriasis: Ceramide-mediated Signal Transduction and its possible Pathophysiological and Therapeutic Relevance”
Other Academic Activities
- 1997 - 2005 | Scientific Secretary of the 366 special research field "Signal Recognition and Implementation” (Speaker: Prof. Dr. W. Reutter)
- Since 1999 | Executive Member of the Board of Trustees, “Berlin Foundation for Dermatology”
- 1999 - 2004 | Member of the Doctoral Commission, Department of Human Medicine
- 1999 - 2000 | Member of the Budgetary Commission, Department of Human Medicine
- 2001 - 2004 | Deputy Speaker of the 276/2 Research Training Group "Signal Recognition and Implementation” (Speaker: Prof. Dr. B. Wiedenmann)
- Since 2001 | Executive Board Member, Langheinrich Foundation Berlin; Appointment as a Member of the Licensing Commission for human medicine (Commission A); Federal Ministry of Health
PATENTS
- W. Reutter, H. Kayser, R. Zeitler, C.C. Geilen (1993)
Novel glycoconjugate with N-substituted neuraminic acid as a means for stimulation of the immune system.
DE 4204907 A1 - W. Reutter, J. Mulzer, K. Buchner, C.C. Geilen, M. Mickeleit Th. Wieder (1998)
A method of producing Glycoside Phospholipide, in particular Glucoside Lecithin, and its proliferation-inhibiting effect on epithelial cells, in particular Keratinocytes.
DE 195 47 827 A1

